Tofacitinib Extended-Release Tablets and Zohydro ER Capsules
Determining the interaction of Tofacitinib Extended-Release Tablets and Zohydro ER Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tofacitinib Extended-Release Tablets-Zoladex
- Tofacitinib Extended-Release Tablets-Zoladex (Goserelin Implant 10.8 mg)
- Tofacitinib Extended-Release Tablets-Zoladex (Goserelin Implant 3.6 mg)
- Tofacitinib Extended-Release Tablets-Zoladex 3-Month
- Tofacitinib Extended-Release Tablets-Zoladex Implant
- Tofacitinib Extended-Release Tablets-Zolate
- Zohydro ER Capsules-Tofacitinib Tablets
- Zohydro ER Capsules-Tofranil
- Zohydro ER Capsules-Tofranil injection
- Zohydro ER Capsules-Tofranil-PM
- Zohydro ER Capsules-Tol-Tab
- Zohydro ER Capsules-Tolazamide